BRPI0403173A - polypeptide, nucleic acid molecule, vector, method for preparing a polypeptide, cell, use of polypeptide and / or nucleic acid and / or vector, pharmaceutical composition, and method of treating a human or animal patient - Google Patents
polypeptide, nucleic acid molecule, vector, method for preparing a polypeptide, cell, use of polypeptide and / or nucleic acid and / or vector, pharmaceutical composition, and method of treating a human or animal patientInfo
- Publication number
- BRPI0403173A BRPI0403173A BRPI0403173-3A BRPI0403173A BRPI0403173A BR PI0403173 A BRPI0403173 A BR PI0403173A BR PI0403173 A BRPI0403173 A BR PI0403173A BR PI0403173 A BRPI0403173 A BR PI0403173A
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptide
- vector
- nucleic acid
- preparing
- human
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"POLIPEPTìDEO, MOLéCULA DE áCIDO NUCLEICO, VETOR, MéTODO PARA PREPARAR UM POLIPEPTìDEO, CéLULA, USO DO POLIPEPTìDEO E/OU DO áCIDO NUCLEICO E/OU DO VETOR, COMPOSIçãO FARMACêUTICA E MéTODO DE TRATAMENTO DE UM PACIENTE HUMANO OU ANIMAL". A invenção diz respeito ao fornecimento de polipeptídeos oligoméricos (dímeros, trímeros etc.) compreendendo os domínios de ligação de ligandos de citocinas que são ligadas através de moléculas ligadoras de polipeptídeos flexíveis. As moléculas ligadoras opcionalmente compreendem sítios sensíveis à protease para modular a liberação de citocinas biologicamente ativas quando administradas a um paciente humano ou animal."POLYPEPTIDE, NUCLEIC ACID MOLECULE, VECTOR, METHOD FOR PREPARING A POLYPEPTIDE, CELL, USE OF POLYPEPTIDE AND / OR VECTOR, PHARMACEUTICAL COMPOSITION, AND MATERIAL AND MATERIAL PATHUTICAL COMPOSITION" The invention relates to the provision of oligomeric polypeptides (dimers, trimers, etc.) comprising cytokine ligand binding domains that are linked via flexible polypeptide linker molecules. Linker molecules optionally comprise protease sensitive sites to modulate the release of biologically active cytokines when administered to a human or animal patient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0403173-3A BRPI0403173A (en) | 2004-07-30 | 2004-07-30 | polypeptide, nucleic acid molecule, vector, method for preparing a polypeptide, cell, use of polypeptide and / or nucleic acid and / or vector, pharmaceutical composition, and method of treating a human or animal patient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0403173-3A BRPI0403173A (en) | 2004-07-30 | 2004-07-30 | polypeptide, nucleic acid molecule, vector, method for preparing a polypeptide, cell, use of polypeptide and / or nucleic acid and / or vector, pharmaceutical composition, and method of treating a human or animal patient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0403173A true BRPI0403173A (en) | 2006-03-21 |
Family
ID=36095939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0403173-3A BRPI0403173A (en) | 2004-07-30 | 2004-07-30 | polypeptide, nucleic acid molecule, vector, method for preparing a polypeptide, cell, use of polypeptide and / or nucleic acid and / or vector, pharmaceutical composition, and method of treating a human or animal patient |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0403173A (en) |
-
2004
- 2004-07-30 BR BRPI0403173-3A patent/BRPI0403173A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Michels et al. | Acid-mediated prevention of aspartimide formation in solid phase peptide synthesis | |
| Brines et al. | Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin | |
| BR0009505A (en) | Lung cancer therapy and diagnosis compounds and processes | |
| RS51602B (en) | April receptor (bcma) and uses thereof | |
| CY1110973T1 (en) | IMPROVED TWO SGP130FC | |
| BR9914708A (en) | Composition of matter, DNA, expression vector, host cell, and, process for preparing a pharmacologically active compound | |
| BR0214137A (en) | Cd40 antibodies, pharmaceutical composition comprising them, use thereof in the manufacture of a medicament, lineage, isolated cell, isolated nucleic acid molecule, vector comprising same, host cell and method of manufacturing said antibodies | |
| BRPI0409136A (en) | pentacyclic heteroaromatic compound and medicinal use thereof | |
| BR9808881A (en) | Compounds for prostate cancer immunotherapy and methods for their use | |
| BR9908823A (en) | Lung cancer therapy and diagnosis compounds and processes | |
| BR9813658A (en) | Glucagon-like peptide-1 crystals | |
| DK0616812T3 (en) | Combination of antihormone compounds and binding molecules to treat cancer | |
| BR0110703A (en) | Amide, a pharmaceutical composition comprising a compound, compounds, use of compounds, processes for the prophylactic or therapeutic treatment of type ii diabetes and for the preparation of such compounds. | |
| DE50004018D1 (en) | USE OF NATURAL PEPTIDES AS ANTIBIOTICALLY ACTIVE SUBSTANCES FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
| DE60209227D1 (en) | 2 - ((N- (2-AMINO-3- (HETEROARYL- OR -ARYL) PROPIONYL) AMINOACYL) AMINO) -ALKYLBORONIC ACID DERIVATIVES | |
| CY1118930T1 (en) | RECONSTRUCTIONED PROTECTION PROTEINS AND METHODS OF INDUSTRIAL CONSTRUCTION AND USE | |
| ES2168361T3 (en) | DNA SEQUENCES FOR METALOPROTEASES OF THE MATRIX, ITS PREPARATION AND EMPLOYMENT. | |
| EA200601738A1 (en) | MODIFIED PROTEINS OF BOUGHINE, CYTOTOXINES AND METHODS OF THEIR APPLICATION | |
| ATE475713T1 (en) | TRANS-LENTIVIRAL VECTOR SYSTEM | |
| DK1687267T3 (en) | Modified MscL protein channel | |
| BRPI0412607A (en) | method for enhancing the efficacy of biological reaction modifying proteins and resulting muteins | |
| HRP20050024A2 (en) | Pegylated t20 polypeptide | |
| BRPI0407031A (en) | Compositions and methods for cancer treatment using igsf9 and liv-1 | |
| WO2003062276A3 (en) | Multimers of receptor-binding ligands | |
| BRPI0403173A (en) | polypeptide, nucleic acid molecule, vector, method for preparing a polypeptide, cell, use of polypeptide and / or nucleic acid and / or vector, pharmaceutical composition, and method of treating a human or animal patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 4A ANUIDADE. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2082 DE 30/11/2010. |